Cell therapy is a promising option for treating ischemic diseases and heart failure. Adult
stem and progenitor cells from various sources have experimentally been shown to augment …

It is well established that cardiovascular repair mechanisms become progressively impaired
with age and that advanced age is itself a significant risk factor for cardiovascular disease …

In the absence of effective endogenous repair mechanisms after cardiac injury, cell-based
therapies have rapidly emerged as a potential novel therapeutic approach in ischaemic …

Cell-based therapy is a promising option for treatment of ischemic diseases. Several cell
types have experimentally been shown to increase the functional recovery of the heart after …

During recent years different types of adult stem/progenitor cells have been successfully
applied for the treatment of many pathologies, including cardiovascular diseases. The …

Cell therapy is a promising option for the treatment of ischemic diseases. Infusion or
injection of stem or progenitor cells has improved neovascularization and heart function after …

OBJECTIVE: Cell therapy has received much attention for its potential to regenerate
ischemic organs, but initial clinical trials in aged patients did not replicate the dramatic …

Cardiovascular disease (CVD) can be separated into two broad etiological categories,
based on the presence or absence of ischemia as a causative factor. In both ischemic and …

The purpose of this review is to summarize current data leading to and arising from recent
clinical application of cellular therapy for acute myocardial infarct (heart attack) and …

Reconstitution of infarcted myocardium with functional new cardiomyocytes and vessels, a
goal that only a few years ago would have been regarded as extravagant, is now actively …